Patients with CIDP had a significantly reduced melanopsin-mediated post-illumination pupil response (PIPR) compared to healthy controls (25% versus 36%; P < 0.01). The gene discussed is OPN4; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.